Literature DB >> 6270164

Expression of angiotensin-converting enzyme activity in cultured pulmonary artery endothelial cells.

P J Del Vecchio, J R Smith.   

Abstract

Angiotensin-converting enzyme (EC 3.4.51.1) is a carboxyterminal dipeptidyl peptidase. The enzyme catalyzes the conversion of the decapeptide angiotensin I to the octapeptide angiotensin II. In addition, the enzyme catabolizes bradykinin. Because of these actions, the enzyme is of pivotal importance in blood pressure homeostasis. Numerous investigators have demonstrated the presence of the enzyme in association with endothelial cells but relatively little is known concerning the factors controlling the expression enzyme activity by endothelial cells in culture. We have demonstrated that endothelial cells in culture do not express significant amounts of enzyme activity until several days after growth ceases due to high cell density. This is important because it demonstrates a change in function with stage of growth in culture and a possible difference in functional capabilities between nondividing endothelial cells and cells that are dividing in response to injury. Since density-dependent expression of differentiated traits does not appear to be unique to endothelial cells an understanding of the mechanisms underlying this phenomenon may provide a general explanation for the expression of differentiated traits by cultured cells.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6270164     DOI: 10.1002/jcp.1041080307

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  26 in total

1.  Stimulus-specific alteration of the relationship between cytosolic Ca(2+) transients and nitric oxide production in endothelial cells ex vivo.

Authors:  O Mizuno; S Kobayashi; K Hirano; J Nishimura; C Kubo; H Kanaide
Journal:  Br J Pharmacol       Date:  2000-07       Impact factor: 8.739

2.  Thrombin-induced generation of neutrophil activating factors in blood.

Authors:  S K Lo; L Lai; J A Cooper; A B Malik
Journal:  Am J Pathol       Date:  1988-01       Impact factor: 4.307

3.  Determination of human factor VIII (AHG-associated protein)--antigen in endothelial cells from Xenopus laevis (XTH cells). Evaluation of a sensitive ELISA technique.

Authors:  W K Schlage
Journal:  Cell Tissue Res       Date:  1986       Impact factor: 5.249

4.  Cell trivision of hyperploid cells.

Authors:  Gabor Nagy; Gabor Kiraly; Melinda Turani; Gaspar Banfalvi
Journal:  DNA Cell Biol       Date:  2013-10-05       Impact factor: 3.311

5.  Involvement of myosin light-chain kinase in endothelial cell retraction.

Authors:  R B Wysolmerski; D Lagunoff
Journal:  Proc Natl Acad Sci U S A       Date:  1990-01       Impact factor: 11.205

Review 6.  A modern understanding of the traditional and nontraditional biological functions of angiotensin-converting enzyme.

Authors:  Kenneth E Bernstein; Frank S Ong; Wendell-Lamar B Blackwell; Kandarp H Shah; Jorge F Giani; Romer A Gonzalez-Villalobos; Xiao Z Shen; Sebastien Fuchs; Rhian M Touyz
Journal:  Pharmacol Rev       Date:  2012-12-20       Impact factor: 25.468

7.  The effect of ethchlorvynol on cultured endothelial cells. A model for the study of the mechanism of increased vascular permeability.

Authors:  R Wysolmerski; D Lagunoff
Journal:  Am J Pathol       Date:  1985-06       Impact factor: 4.307

8.  Enhancement of human polymorphonuclear leukocyte adherence to plastic and endothelium by phorbol myristate acetate. Comparison with human C5a.

Authors:  R O Webster; R B Wysolmerski; D Lagunoff
Journal:  Am J Pathol       Date:  1986-11       Impact factor: 4.307

9.  Dexamethasone selectively regulates the activity of enzymatic markers of cerebral endothelial cell lines.

Authors:  L Juillerat-Jeanneret; A Aguzzi; O D Wiestler; P Darekar; R C Janzer
Journal:  In Vitro Cell Dev Biol       Date:  1992 Jul-Aug

10.  Flows of liquid and electrical current through monolayers of cultured bovine arterial endothelium.

Authors:  M R Turner
Journal:  J Physiol       Date:  1992-04       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.